Trailing-twelve-month (TTM) revenue is $12.24 Billion with a year-over-year growth of +10.29%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-27 | $3,009,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-10-30 |
| Q4 FY2025Period ended 2025-12-31 | $3,380,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-12 |
| Q1 FY2026Period ended 2026-04-04 | $2,714,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-07 |
| Q2 FY2026Period ended 2026-07-04 | $3,133,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-05 |
| TTM revenue | $12,236,000,000 |
Current P/S: $77,380,695,360 market capitalization ÷ $12,236,000,000 TTM revenue = 6.32x.
Market capitalization source: FMP quote. Quote observed 2026-09-11T20:00:02.000Z. Latest revenue period ended 2026-07-04.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-07-04): $3.13B.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-12T00:15:50.048Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-10.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Product | $4.1B | $4.6B | $5.4B | $5.8B | $6.5B | $6.8B |
| Service | $3.3B | $3.6B | $3.7B | $4.2B |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| International | $2.4B | $2.6B | $2.7B | $3.0B | $3.0B | $2.7B |
| North America | $5.0B | $5.6B | $6.4B | $6.9B |
$12.24B
$12.24 Billion
+10.29%
vs. $11.09B a year ago (TTM)
+9.18%
5 Year compound annual growth rate
1 Year
+10.29%
3 Year
+8.20%
5 Year
+9.18%
10 Year
+7.88%
15 Year
+0.48%
20 Year
(5.74%)
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $11.68B | +$865.00M | +8.00% |
| 2024 | $10.82B | +$839.00M | +8.41% |
| 2023 | $9.98B | +$866.00M | +9.50% |
| 2022 | $9.11B | +$941.00M | +11.52% |
| 2021 | $8.17B | +$757.00M | +10.21% |
| 2020 |
TTM Growth
+10.29%
3-Year CAGR
+8.20%
5-Year CAGR
+9.18%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-12T00:15:50.048Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-10.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $4.9B |
| $8.4B |
| UNITED KINGDOM | N/A | N/A | N/A | N/A | N/A | $603M |
|---|
| $7.41B |
| ($473.00M) |
| (6.00%) |
| 2019 | $7.89B | +$544.00M | +7.41% |
| 2018 | $7.34B | +$963.00M | +15.09% |
| 2017 | $6.38B | +$342.00M | +5.66% |
| 2016 | $6.04B | +$343.00M | +6.02% |
